SHA/600196 (SHA/600196)

Shanghai Stock Exchange: SHA/600196 · CNY

CN¥23.0

+0.26 (+1.1%)· Recorded snapshot

Market cap	56.3B
Revenue (ttm)	42.7B
Net income (ttm)	3.5B
EPS (ttm)	CN¥1.33
Shares out	2.7B
P/E (trailing)	17.3x
P/E (forward)	34.9x
Dividend	CN¥0.39 (1.70%)
Volume	13,995,917
Beta	0.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 42.7B
Net income (ttm): 3.5B
EPS (ttm): CN¥1.33
P/E (trailing): 17.3x
P/E (forward): 34.9x
Market cap: 56.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E34.9

P25 n/aP50 n/aP75 n/a

Trailing P/E17.3

P25 n/aP50 n/aP75 n/a

ROE7

P25 n/aP50 n/aP75 n/a

ROIC2.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHA/600196 indicators

Market & fundamental data

Available fields

257

Groups with data

Currency

CNY

Showing 257 of 257 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-27
Employees	40,684
Employees change	81
Employees growth	0.2%
Enterprise value	CNY 97.5B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1994
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CNE000000X38
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Last stock split date	2010-07-26
Last stock split type	Forward
Market cap	CNY 56.3B
Next earnings date	2026-10-28
Price	CNY 23.01
Price currency	CNY
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	sha/600196
Website	https://www.fosunpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	24.81x
Average P/E ratio (3Y)	22.4x
Average P/E ratio (5Y)	22.47x
Earnings yield	5.78%
EV/Earnings	27.75x
EV/EBIT	32.83x
EV/EBITDA	14.31x
EV/Sales	2.28x
FCF / EV yield	-0.3%
FCF yield	-0.51%
Forward P/E	34.86x
Graham number	23.7997
Graham upside	3.43%
Industry forward P/E	18.72x
Industry P/E	33.27x
Lynch fair value	CNY 6.65
Lynch upside	-71.1%
P/(OCF - SBC) ratio	11.15x
P/B ratio	0.85x
P/E ratio	17.3x
P/OCF ratio	10.71x
P/S ratio	1.32x
Price / tangible book value	2.24x
Price/EBITDA ratio	8.74x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.95%
EBITDA margin	15.09%
Effective tax rate	13.86%
Gross margin	50.92%
Operating margin	6.95%
Pretax margin	12.06%
Profit margin	8.23%
Profit per employee	CNY 86,564
Profitable quarters	82
Profitable years	31
Revenue per employee	CNY 1.1M
ROA	1.52%
ROA (5Y)	1.53%
ROCE	3.25%
ROE	7%
ROE (5Y)	7.3%
ROIC	2.88%
ROIC (5Y)	3.15%
SBC / revenue	0.49%
Tax / revenue	1.67%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	7.46%
EPS growth (Q)	16.2%
EPS growth (QoQ)	12.55%
EPS growth 10Y	1.21%
EPS growth 3Y	-0.12%
EPS growth 5Y	-6.36%
EPS growth years	2
Gross profit growth	15.82%
Gross profit growth (Q)	4.17%
Gross profit growth 3Y	1.34%
Gross profit growth 5Y	4.37%
Net income growth	7.07%
Net income growth (Q)	15.18%
Net income growth (QoQ)	11.21%
Net income growth 3Y	-0.59%
Net income growth 5Y	-5.84%
Net income growth years	2
OCF growth	7.93%
OCF growth (Q)	-19.6%
OCF growth (QoQ)	-21.34%
OCF growth 10Y	10.25%
OCF growth 3Y	14.15%
OCF growth 5Y	10.85%
Operating income growth	20.91%
Operating income growth (Q)	32.85%
Operating income growth 3Y	13.28%
Operating income growth 5Y	2.88%
Revenue growth	8.05%
Revenue growth (Q)	1.44%
Revenue growth (QoQ)	-3.35%
Revenue growth 10Y	11.67%
Revenue growth 3Y	-0.23%
Revenue growth 5Y	3.92%
Revenue growth quarters	3
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -5.5B
Depreciation and amortization	CNY 3.5B
EBIT	CNY 3B
EBITDA	CNY 6.4B
EPS	CNY 1.33
FCF per share	CNY -0.11
Financing cash flow	CNY 3B
Free cash flow	CNY -287.9M
Free cash flow minus SBC	CNY -495.2M
Gross profit	CNY 21.8B
Income taxes	CNY 714.5M
Investing cash flow	CNY -6.2B
Net borrowing	CNY 2.9B
Net cash flow	CNY 1.6B
Net income	CNY 3.5B
Operating cash flow minus SBC	CNY 5.1B
Operating income	CNY 3B
Revenue	CNY 42.7B
Stock-based compensation	CNY 207.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.4
Book value per share	CNY 18.93
Debt / EBITDA	6.04
Debt / equity	0.62
Goodwill	CNY 10.8B
Interest coverage	2.45
Long-term assets	CNY 92.2B
Long-term liabilities	CNY 25.4B
Net cash (debt)	CNY -25.4B
Net cash / market cap	-45.14%
Net debt / EBITDA	3.94
Net debt / equity	0.38
Piotroski F-Score	7
Property, plant and equipment	CNY 23.9B
Shareholders' equity	CNY 66.1B
Tangible book value	CNY 25.1B
Tangible book value per share	CNY 9.44
Total assets	CNY 126.8B
Total cash	CNY 15.8B
Total debt	CNY 41.2B
Total liabilities	CNY 60.7B
WACC	4.74%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.35
Current assets	CNY 34.5B
Current liabilities	CNY 35.3B
Current ratio	0.98
Inventory turnover	3.27
Net working capital	CNY 6.4B
Quick ratio	0.75
Working capital	CNY -760.2M
Working capital turnover	-23.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.63%
Dividend growth	21.88%
Dividend growth (10Y)	2%
Dividend growth (3Y)	-2.44%
Dividend growth (5Y)	-1.93%
Dividend growth years	1
Dividend payment date	2026-07-27
Dividend payment years	26
Dividend payout frequency	Annual
Dividend per share	CNY 0.39
Dividend yield	1.7%
Ex-dividend date	2026-07-27
FCF payout ratio	147.11%
Last dividend	CNY 0.39
Payout ratio	70.75%
Shareholder yield	2.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-1.46%
10Y return CAGR	1.02%
10Y total return	10.64%
150-day SMA	CNY 23.71
15Y price change	138.69%
15Y return CAGR	7.3%
15Y total return	187.6%
1D price change	1.14%
1M price change	0.74%
1M total return	0.74%
1W price change	-0.56%
1W total return	-0.56%
1Y price change	-21.23%
1Y return CAGR	-19.86%
1Y total return	-19.85%
20-day SMA	CNY 23.25
200-day SMA	CNY 24.47
20Y price change	665.72%
20Y return CAGR	11.95%
20Y total return	855.27%
3M price change	1.14%
3M total return	1.14%
3Y price change	-18.06%
3Y return CAGR	-5.15%
3Y total return	-14.67%
50-day SMA	CNY 23.02
50-day SMA vs 200-day SMA	50under200
52-week high	CNY 29.68
52-week high date	2025-11-03
52-week low	CNY 20.85
52-week low date	2026-06-29
5Y price change	-53.73%
5Y return CAGR	-13.12%
5Y total return	-50.49%
6M price change	-9.3%
6M total return	-7.71%
All-time high	CNY 91.69
All-time high date	2021-08-05
All-time low	CNY 2.13
All-time low date	2006-04-26
Average true range (ATR)	CNY 0.55
Average volume	18.6M
Beta (1Y)	0.21
Beta (2Y)	0.29
Beta (5Y)	0.38
Change from 52-week high	-22.47%
Change from 52-week low	10.36%
Change from all-time high	-74.9%
Change from all-time low	981.3%
Change from open	0.17%
Day's gap	0.97%
Dollar volume	CNY 322M
High price	CNY 23.24
Low price	CNY 22.79
Monthly RSI	41.56
Open price	CNY 22.97
Position in 52-week range	48.89%
Previous close	CNY 22.75
Price vs 150-day SMA	-2.94%
Price vs 20-day SMA	-1.05%
Price vs 200-day SMA	-5.97%
Price vs 50-day SMA	-0.04%
Relative volume	0.76
RSI	49.42
Sharpe ratio	-0.73
Sharpe ratio (3Y)	-0.2
Sharpe ratio (5Y)	-0.6
Sortino ratio	-0.82
Sortino ratio (3Y)	-0.08
Sortino ratio (5Y)	-0.69
Volume	14M
Weekly RSI	46.01
YTD price change	-13.14%
YTD total return	-11.62%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.6B
Shares change (QoQ)	-1.19%
Shares change (YoY)	-0.63%
Shares held by insiders	0.62%
Shares held by institutions	15.37%
Shares outstanding	2.7B

Deeper analysis on SHA/600196

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHA/600196 report

Is a complete SHA/600196 research report available?

No complete published report is available for sha/600196 (SHA/600196) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHA/600196 (SHA/600196)

Price

Financial snapshot

Fair-value bridge

Latest news · SHA/600196

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHA/600196 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHA/600196

Frequently asked questions